A citation-based method for searching scientific literature

Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese, Irving Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh. N Engl J Med 2013
Times Cited: 1352







List of co-cited articles
538 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
45

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
660
34

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
342
32

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
31

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Gert van Assche, Walter Reinisch, Jean-Frederic Colombel, Geert D'Haens, Douglas C Wolf, Martina Kron, Mary Beth Tighe, Andreas Lazar, Roopal B Thakkar. Gastroenterology 2012
782
30

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
821
24

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers,[...]. N Engl J Med 2019
231
23

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Brian G Feagan, Colleen Marano, Hongyan Zhang, Richard Strauss, Jewel Johanns, Omoniyi J Adedokun, Cynthia Guzzo, Jean-Frederic Colombel, Walter Reinisch,[...]. Gastroenterology 2014
538
20

The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, William Sandborn, Silvio Danese, Geert D'Haens, Remo Panaccione, Edward V Loftus, Serap Sankoh, Irving Fox,[...]. Gut 2017
426
17

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Walter Reinisch, William J Sandborn, Daniel W Hommes, Geert D'Haens, Stephen Hanauer, Stefan Schreiber, Remo Panaccione, Richard N Fedorak, Mary Beth Tighe, Bidan Huang,[...]. Gut 2011
574
16

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
William J Sandborn, Brian G Feagan, Colleen Marano, Hongyan Zhang, Richard Strauss, Jewel Johanns, Omoniyi J Adedokun, Cynthia Guzzo, Jean-Frederic Colombel, Walter Reinisch,[...]. Gastroenterology 2014
460
15

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian,[...]. J Crohns Colitis 2017
579
15

ACG Clinical Guideline: Ulcerative Colitis in Adults.
David T Rubin, Ashwin N Ananthakrishnan, Corey A Siegel, Bryan G Sauer, Millie D Long. Am J Gastroenterol 2019
435
13

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Remo Panaccione, Subrata Ghosh, Stephen Middleton, Juan R Márquez, Boyd B Scott, Laurence Flint, Hubert J F van Hoogstraten, Annie C Chen, Hanzhe Zheng, Silvio Danese,[...]. Gastroenterology 2014
561
13

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
13

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
William J Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi, Xiaopan Yao, Jingjing Chen, Maria Rosario, Siddharth Bhatia, Krisztina Kisfalvi,[...]. Gastroenterology 2020
67
19

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D'Amico, Jasbir Dhaliwal, Anne M Griffiths, Dominik Bettenworth, William J Sandborn, Bruce E Sands, Walter Reinisch,[...]. Gastroenterology 2021
236
12

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
11

Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Bruce E Sands, Brian G Feagan, Paul Rutgeerts, Jean-Frédéric Colombel, William J Sandborn, Richmond Sy, Geert D'Haens, Shomron Ben-Horin, Jing Xu, Maria Rosario,[...]. Gastroenterology 2014
426
10

First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
Siddharth Singh, Mohammad Hassan Murad, Mathurin Fumery, Parambir S Dulai, William J Sandborn. Clin Gastroenterol Hepatol 2020
92
10

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
10

An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab.
Tim Wyant, Eric Fedyk, Brihad Abhyankar. J Crohns Colitis 2016
106
9

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, Robert Enns, Stephen B Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D Kent,[...]. Gastroenterology 2007
9

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Brian G Feagan, Geert D'Haens, Douglas C Wolf, Igor Jovanovic, Stephen B Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y Hua, Ji Hwan Lee,[...]. N Engl J Med 2021
30
30

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
Julien Kirchgesner, Magali Lemaitre, Fabrice Carrat, Mahmoud Zureik, Franck Carbonnel, Rosemary Dray-Spira. Gastroenterology 2018
248
8

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L Peyrin-Biroulet, W Sandborn, B E Sands, W Reinisch, W Bemelman, R V Bryant, G D'Haens, I Dotan, M Dubinsky, B Feagan,[...]. Am J Gastroenterol 2015
8

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.
Giulia Roda, Bindia Jharap, Narula Neeraj, Jean-Frederic Colombel. Clin Transl Gastroenterol 2016
285
8

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Brian G Feagan, Silvio Danese, Edward V Loftus, Séverine Vermeire, Stefan Schreiber, Timothy Ritter, Ronald Fogel, Rajiv Mehta, Sandeep Nijhawan, Radosław Kempiński,[...]. Lancet 2021
42
19

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
William J Sandborn, Brian G Feagan, Edward V Loftus, Laurent Peyrin-Biroulet, Gert Van Assche, Geert D'Haens, Stefan Schreiber, Jean-Frederic Colombel, James D Lewis, Subrata Ghosh,[...]. Gastroenterology 2020
70
10

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Séverine Vermeire, Stefan Schreiber, Robert Petryka, Tanja Kuehbacher, Xavier Hebuterne, Xavier Roblin, Maria Klopocka, Adrian Goldis, Maria Wisniewska-Jarosinska, Andrey Baranovsky,[...]. Lancet 2017
238
7


Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B Gecse, Ailsa L Hart, Pieter Hindryckx,[...]. J Crohns Colitis 2017
790
7

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.
William J Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranic, Chinyu Su, Samantha Rousell, Wojciech Niezychowski. N Engl J Med 2012
519
7

Ulcerative colitis.
Silvio Danese, Claudio Fiocchi. N Engl J Med 2011
751
7

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.
Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O Lindsay, Laurent Peyrin-Biroulet, Garret J Cullen, Marco Daperno, Torsten Kucharzik,[...]. J Crohns Colitis 2017
7

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
545
7

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.
K Geboes, R Riddell, A Ost, B Jensfelt, T Persson, R Löfberg. Gut 2000
538
7

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
William J Sandborn, Julián Panés, Geert R D'Haens, Bruce E Sands, Chinyu Su, Michele Moscariello, Thomas Jones, Ron Pedersen, Gary S Friedman, Nervin Lawendy,[...]. Clin Gastroenterol Hepatol 2019
114
6

Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
Sebastian Zeissig, Elisa Rosati, C Marie Dowds, Konrad Aden, Johannes Bethge, Berenice Schulte, Wei Hung Pan, Neha Mishra, Maaz Zuhayra, Marlies Marx,[...]. Gut 2019
99
6

Long-term safety of vedolizumab for inflammatory bowel disease.
Edward V Loftus, Brian G Feagan, Remo Panaccione, Jean-Frédéric Colombel, William J Sandborn, Bruce E Sands, Silvio Danese, Geert D'Haens, David T Rubin, Ira Shafran,[...]. Aliment Pharmacol Ther 2020
30
20

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
Joseph D Feuerstein, Kim L Isaacs, Yecheskel Schneider, Shazia Mehmood Siddique, Yngve Falck-Ytter, Siddharth Singh. Gastroenterology 2020
123
6

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager,[...]. J Crohns Colitis 2020
297
6

Ulcerative colitis as a progressive disease: the forgotten evidence.
Joana Torres, Vincent Billioud, David B Sachar, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Inflamm Bowel Dis 2012
137
6

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Brian G Feagan, David T Rubin, Silvio Danese, Severine Vermeire, Brihad Abhyankar, Serap Sankoh, Alexandra James, Michael Smyth. Clin Gastroenterol Hepatol 2017
104
6

Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
S Lichtiger, D H Present, A Kornbluth, I Gelernt, J Bauer, G Galler, F Michelassi, S Hanauer. N Engl J Med 1994
6

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis.
William J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, Michael Chiorean, Séverine Vermeire, Scott D Lee, Tanja Kühbacher, Bruce Yacyshyn, Christopher H Cabell, Snehal U Naik,[...]. Gastroenterology 2020
60
10

ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. Am J Gastroenterol 2018
483
5

Ulcerative colitis.
Ingrid Ordás, Lars Eckmann, Mark Talamini, Daniel C Baumgart, William J Sandborn. Lancet 2012
948
5

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
William J Sandborn, Subrata Ghosh, Julian Panes, Stefan Schreiber, Geert D'Haens, Satoshi Tanida, Jesse Siffledeen, Jeffrey Enejosa, Wen Zhou, Ahmed A Othman,[...]. Gastroenterology 2020
64
7

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Cynthia Guzzo, Bruce E Sands, Stephen B Hanauer, Stephan Targan, Paul Rutgeerts,[...]. N Engl J Med 2012
731
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.